Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1184134359
总结
TPMT *1/*2 + *1/*3A + *3A/*3B is associated with increased risk of leukopenia when treated with mercaptopurine and methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to TPMT *1/*1.